TY - JOUR
T1 - The patient perspective on remission in rheumatoid arthritis
T2 - 'You've got limits, but you're back to being you again'
AU - Van Tuyl, Lilian H.D.
AU - Hewlett, Sarah
AU - Sadlonova, Martina
AU - Davis, Bev
AU - Flurey, Caroline
AU - Hoogland, Wijnanda
AU - Kirwan, John
AU - Sanderson, Tessa
AU - Van Schaardenburg, Dirkjan
AU - Scholte-Voshaar, Marieke
AU - Smolen, Josef
AU - Stamm, Tanja
AU - Boers, Maarten
N1 - Publisher Copyright: © 2015, BMJ Publishing Group. All rights reserved.
PY - 2015/6/1
Y1 - 2015/6/1
N2 - Objectives: The aim of rheumatoid arthritis (RA) treatment is remission. As treatment should be targeted at outcomes relevant to patients, it is important to understand how patients perceive remission, and to assess whether the current definition of remission adequately reflects these perceptions. The objective of this study is to explore the patient perspective on remission in RA. Methods: Nine focus-group discussions in Austria, The Netherlands and UK were conducted, including patients in American College of Rheumatology (ACR)/ European League of Rheumatology (EULAR) remission, self-declared remission and in moderate/high disease activity. Moderators employed a prespecified interview guide helped to engage patients in a discussion on their experience with remission. Inductive thematic analysis was performed within each country, and identified themes were discussed across countries. Results: 47 RA patients (66% women, disease duration 9 years) participated. Three major themes of patient-perceived remission emerged: (1) symptoms would either be absent or strongly reduced, (2) impact of the disease on daily life would diminish by increased independence, ability to do valued activities, improved mood and ability to cope; (3) leading to a return to normality, including work, family role and perception of others. Patients felt the concept of remission was influenced by ageing, side effects of medication, comorbidities, accrued damage to joints and disease duration. Opinions on duration of state, the role of medication and measurement instruments varied widely. Conclusions: Patients characterise remission by the absence or reduction of symptoms, but more directly by decreased daily impact of their condition and the feeling of a return to normality. The next step is to study whether an additional patient-perceived measure of remission may add value to the ACR/EULAR definition of remission.
AB - Objectives: The aim of rheumatoid arthritis (RA) treatment is remission. As treatment should be targeted at outcomes relevant to patients, it is important to understand how patients perceive remission, and to assess whether the current definition of remission adequately reflects these perceptions. The objective of this study is to explore the patient perspective on remission in RA. Methods: Nine focus-group discussions in Austria, The Netherlands and UK were conducted, including patients in American College of Rheumatology (ACR)/ European League of Rheumatology (EULAR) remission, self-declared remission and in moderate/high disease activity. Moderators employed a prespecified interview guide helped to engage patients in a discussion on their experience with remission. Inductive thematic analysis was performed within each country, and identified themes were discussed across countries. Results: 47 RA patients (66% women, disease duration 9 years) participated. Three major themes of patient-perceived remission emerged: (1) symptoms would either be absent or strongly reduced, (2) impact of the disease on daily life would diminish by increased independence, ability to do valued activities, improved mood and ability to cope; (3) leading to a return to normality, including work, family role and perception of others. Patients felt the concept of remission was influenced by ageing, side effects of medication, comorbidities, accrued damage to joints and disease duration. Opinions on duration of state, the role of medication and measurement instruments varied widely. Conclusions: Patients characterise remission by the absence or reduction of symptoms, but more directly by decreased daily impact of their condition and the feeling of a return to normality. The next step is to study whether an additional patient-perceived measure of remission may add value to the ACR/EULAR definition of remission.
UR - http://www.scopus.com/inward/record.url?scp=84934956022&partnerID=8YFLogxK
U2 - https://doi.org/10.1136/annrheumdis-2013-204798
DO - https://doi.org/10.1136/annrheumdis-2013-204798
M3 - Article
C2 - 24521737
SN - 0003-4967
VL - 74
SP - 1004
EP - 1010
JO - Annals of the rheumatic diseases
JF - Annals of the rheumatic diseases
IS - 6
ER -